Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT
· Real-Time Price · USD
7.68
-0.99 (-11.42%)
At close: Aug 15, 2025, 3:59 PM
7.83
1.95%
After-hours: Aug 15, 2025, 07:47 PM EDT
Sagimet Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Net Income | -10.39M | -18.18M | -16.2M | -14.62M | -8.12M | -6.63M | -8.15M | -6.35M | -6.79M | -6.59M | -7.2M | -7.47M | -7.1M | -8.73M | -5.55M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 35K | 34K | 34K | n/a | n/a | n/a | 32K | 33K |
Stock-Based Compensation | 1.6M | 1.47M | 1.53M | 1.55M | 1.45M | 759K | 1.31M | 1.85M | 1.06M | 767K | 721K | 389K | 383K | 387K | 729K |
Other Working Capital | -125K | -726K | 3.22M | 364K | 1.48M | 601K | -280K | 587K | 376K | -72K | 76K | -155K | -119K | 3.65M | -868K |
Other Non-Cash Items | -188K | 2.89M | -19K | -6.29M | 649K | -157K | 37K | -4K | 29K | 1K | -50K | -56K | -9K | 30K | 784K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -125K | -726K | 3.66M | -205K | 386K | -181K | -280K | 588K | -21K | -1.26M | -929K | 900K | 590K | 3.65M | -868K |
Operating Cash Flow | -9.1M | -14.54M | -11.02M | -19.57M | -5.63M | -6.21M | -7.08M | -3.88M | -5.72M | -7.08M | -7.45M | -6.23M | -6.14M | -4.67M | -4.9M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -42.95M | -15.57M | -13.76M | -94.33M | -82.95M | n/a | -19.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 29.66M | 18.99M | 23.61M | 12M | 7.79M | 3M | n/a | n/a | 12.8M | 19.4M | 5.44M | 4M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 82.95M | n/a | n/a | n/a | n/a | 12.8M | 19.4M | 5.44M | 4M | -41.45M | n/a | n/a |
Investing Cash Flow | -13.29M | 3.41M | 9.85M | 624K | -75.16M | 3M | -19.62M | n/a | 12.8M | 19.4M | 5.44M | 4M | -41.45M | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 105.75M | n/a | -27K | -904K | n/a | 1.05M | -910K | -136K | -55K | n/a | -30K | 12K | 148K |
Financial Cash Flow | 1K | n/a | n/a | n/a | -27K | 104.85M | 3.52M | 87.21M | -910K | -136K | -55K | n/a | -30K | 12K | 11.14M |
Net Cash Flow | -22.39M | -11.12M | -1.17M | -18.95M | -80.82M | 101.64M | -26.7M | 83.33M | 6.17M | 12.18M | -2.07M | -2.23M | -47.61M | -4.65M | 6.24M |
Free Cash Flow | -9.1M | -14.54M | -11.02M | -19.57M | -5.63M | -6.21M | -7.08M | -3.88M | -5.72M | -7.08M | -7.45M | -6.23M | -6.14M | -4.67M | -4.9M |